As the horizon for the Sustainable Development Goals (SDGs) approaches, progress towards target 3.4 —reducing premature mortality from non-communicable diseases (NCDs) by one-third—remains largely ...

Dementia is one of the most pressing challenges for health and social care globally, with an estimated annual economic burden of £42 billion in the UK alone. The specific toll on individuals and their ...

Dementia is a major public health challenge. 55 million people live with dementia worldwide. Alzheimer's disease accounts for ...

Over the last three decades, the evidence on how to best treat the cognitive and non-cognitive symptoms of patients with ...

Given the time constraints in clinical care and research, few clinicians would invest time in writing a case report on a failed treatment approach. This publication bias explains why we should be ...

Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies ...

Sweeping federal spending cuts, new cost-sharing rules, and eligibility restrictions for public health insurance and food aid will disproportionately affect vulnerable children across the USA, with ...

Although type 2 diabetes is often regarded as a disease of ageing, cases of type 2 diabetes in children and adolescents have ...

The Presidential Proclamation of June 4, 2025, barring entry to the USA to individuals from 12 nations has created an immediate and preventable crisis for the US health-care system.1 Although intended ...

An outbreak caused by a novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in Wuhan in December 2019,1 and has since spread within China and to ...

With international journalists banned from Gaza, health workers are increasingly having to bear witness to events there.

In the past decade, the treatment landscape for non-oncogene-addicted non-small-cell lung cancer (NSCLC) has changed substantially. Immune checkpoint inhibitors, either alone or combined with ...